Abstract: More than 30% of preterm children born before 30 weeks' gestational age establish neonatal Chronic lung disease (CLD), also called bronchopulmonary dysplasia (BPD), a disease with significant morbidity and mortality. In this review paper the main aim was to discuss and overview the recent advances in treatment approaches for the prevention and management of chronic lung disease (CLD) in infant, by other words bronchopulmonary dysplasia (BPD), and discuss approaches with future potential. This review is based on published meta-analyses, randomized controlled trials (RCTs), systematic reviews, individual clinical studies, but only studies which were related to Chronic lung disease (CLD), and mostly the management therapy of this condition in infancy, this was done by performing an electronic search among the databases; PubMed, and Embase, through the period until December 2016, we Included all relevant articles and restricted our search to English published articles with human, and animal subjects. Numerous therapy techniques for CLD have been assessed in well-conducted medical trials and meta-analyses. Although for a few of these therapies conclusive proof of efficacy is doing not have there are numerous continuous areas of research study that show potential.
Keywords: Chronic lung disease (CLD), Broncho Pulmonary Dysplasia (BPD), Randomized Controlled Trials (RCTs).
Title: Pulmonary Disease (Chronic Lung Disease) in Infants; Overview of Proper Management
Author: Abrar Saeed Baraweih, Asma fawzi Hassan hijji, Raniah Mohsen Abdullah Bin Mahfooz, Ragaa awad keyaty Ali, Sara saeed ahmed Alzahrani
International Journal of Healthcare Sciences
ISSN 2348-5728 (Online)
Research Publish Journals
